Besides acting directly on endothelial AT1R and causing endothelial dysfunction, ANGII may act indirectly via asymmetric dimethyl arginine (ADMA), which is an endogenous eNOS inhibitor [46]. Here, AGTR1 is linked to endothelial dysfunction.